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Abstract 
We reviewed the case records of all children admitted to the Aga Khan University Hospital (AKUH)
with a diagnosis of Haemolytic Uremic Syndrome (HUS) over a 7 year period (July, 1988 - June,
1995). A total of 33 patients were admitted to the Pediatric ward at (AKUH) with a median age of 16
months (range 4 months -9 years). 97% cases identified were of the classic variety and no familial case
was identified. The mean duration of illness was 27 days, 39% had an illness >28 days. Diarrhoea and
prior antibiotic used was in 97% patients. Oliguria at admission was seen in 52.5% and seizures in 24%
of cases. Thrombocy topenia, anemia and leucocytosis at admission was present in >72% of children,
Hyponatremia was present in 42% while acidosis, hypocalcemia and hyperkalemia was seen in 30% of
children. Despite optimal management and peritoneal dialysis in 14(42%) patients, 8(24%) died, No
specific relationship was found between mortality and any clinical or laboratory feature at presentation.
Our data highlights the importance of HUS in the Pediatric age group and the need for further studies to
delineate risk factors for adverse outcome (JPMA 48:100,1998).
Introduction 
Haemolytic Uraemic Syndmme (HUS) is a heterogenous group of disorders characterized by
microangiopathic hemolytic anemia, th.rombocytopenia and azotemia. It is one of the leading cause of
acute renal failure in children.
The classical type of HUS, most often occurs with a diarrhoeal prodrome in children younger than 5
years of age, although the syndrome has been reported in persons of all ages and in association with
many different illnesses, organisms and medications1,2. Since the mid-seventies, the mainstay of
treatment for children with HUS has been peritoneal dialysis and blood transfusions alongwith
supportive care.
Peritoneal dialysis and adequate supportive care have played a major role in decreasing mortality from
40% to 4%3, There is a paucity of information related to HUS in Pakistan. This retrospective review
was carried out to investigate the clinical features, mode of presentation and outcome, as well as to see
if there were any predictable prognostic factors for adverse outcome.
Patients, Materials and Methods 
We reviewed the medical records of children seen at the Aga Khan Hospital, Karachi, between July,
1988 to June, 1995, with a discharge diagnosis ofHUS corresponding to the International Classification
of Disease Code 9th Revision Clinical modification 283.11. Medical records were abstracted using
standard data collection form. Information was collected on history, clinical course of illness and
outcome.
The laboratory values abstracted included complete blood cell count, differential cell count, platelet
count, peripheral smear, prothrombin time (PT), partial thromboplastin time (PTF), fibnn degradation
products (FDP’s), serum sodium, potassium, blood urea nitrogen, creatinine, calcium, phosphorus, stool
and urine routine analysis and culture and blood culture. These values were recorded at admission and
at one week of hospital stay. The urine volume for each 24 hour period was recorded and calculated as
mIJm2 and the minimum value was identified for each patient. Facilities for detection of E. Coli
verocytotoxin was not available. Oliguna was defined as urine output <400 ml/m2/24 hours.
Thrombocytopema was defined as platelet count <150x10 6/l, leukocytosis as WBC >15x10 /1 and
anemia was defined as haemoglobin level <10 gm/dl.
The association of risk factors with adverse outcome/mortality was then evaluated by univariate
methods, computation of relative risks, corresponding 95% confidence intervals and analysis of
variance. Significance was set at 5%. Marginal and significant factors were further evaluated in a
logistic regression model using EGRET (SERC and CYTEL, 1991).
Results 
A total of thirty three patients wcre admitted with the diagnoses of HUS.
Figure 1 shows annual trend ofHaemolytic Uraemic Syndrome. There seems to have been an upsurge
for the year 1989- 1990, as more than 50% of the total number of cases were seen during that period.
Seasonal variation was also noted as majority of cases appeared in summer months.
The ages of children ranged from 4-144 months with a mean of 31±37 months and median age of 16
months.
18 children were males while 15 were females. The mean length of stay in hospital was 16± 12 days.
Mortality rate was 8 (24%). 13 patients had a stay >28 days. The mean duration of illness of 15-28 days
was 17 days while mean duration of illness of>28 days was 13 days. 32 (97%) of children were
admitted with diarrhoea as the prodromal symptom, 78% had invasive gastroenteritis as characterized
by stool detailed report showing >20 WBC and >10 RBC. One atypical case was seen with diarrhoea
not being the presenting symptom. Stool cultures showed a positive yield in 7 (21%) patients. 3 (9.1%)
had stool cultures reported as E. coli. Salmonella group A, group B, Salmonella paratyphi B and
Shigella Dysentrae Type 1 were isolated in the stools of the remaining 4 patients.
Blood cultures were positive in4 (12%). The organisms identified included S. typhirnurium, EPEC and
Pseudomonas. One child was polyuric and was considered to be in the recovery phase of the illness.
60% of children continued to have oliguria for greater than one week during their hospital stay. There
was no correlation between those children who were oliguric for >1 week in hospital and mortality.
60% children were oliguric and mortality in these children was 18%, while non oliguric children (39%)
had a mortality of 6%.
Twenty-eight children had a raised creatinine value of >1 mg/dl. BUN values ranged from 3 mg/dl to
222rng/dl with a mean value of 65.5mg/dl. Creatinine values ranged from 0.6mg/dl to 19.3 mg/dl with
a mean of 3.4 ing/dl. 25 (75%) were anemic on admission with a mean haernoglobin value of 8.4
gm/dl. Thrombocytopenia was correlated with age. 36% children <14 months had thrombocytopenia
one week of hospital stay. 50% of children having seizures were hyponatremic. However, there was no
significant correlation found between seizures and hyponatreniia. There was also no correlation
between the occurrence of seizures and the neurological status at admission. Relative risk for seizure
with hyponatremia was 0.94 (p= 0.78).
Serum p Potassium values ranged from 1.2-7.7 mmoI/I with hyperkalemia seen in 9 children.
Management was mainly supportive including plasma infusion, fluids and electrolyte administration.
14 patients underwent dialysis but dialyzed while, in the remaining 25 children surviving, 11(44%)
were dialyzed. Relative risk of survival with dialysis was 1.07 (P=0.73). Risk factors for mortality were
assessed with hyponatremia, hyperkalemia, hypokalemia. hypocalcemia, anaemia, leucocytosis,
oliguria, duration of illness, neurological illness and prior antibiotic therapy. No significant correlation
was found with any variable (Table II).
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